Contralateral Renal Cell Carcinoma Ureteric Metastases Can Arise on Tyrosine Kinase Adjuvant Therapy and Be Effectively Treated by Endoscopic Laser Excision and Ablation

Renal cell carcinoma (RCC) uncommonly metastasizes to the ureter and rarely to the contralateral ureter. We describe the presentation of 2 successive contralateral ureteric metastases from RCC in our institution. The first represents the only reported metachronous ureteric deposit on adjuvant sorafe...

Descripción completa

Detalles Bibliográficos
Autores principales: Reid, Sarah L., Arestis, Nikolas J., McIlhenny, Craig, Lamb, Gavin W. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102019/
https://www.ncbi.nlm.nih.gov/pubmed/25105052
http://dx.doi.org/10.1155/2014/359352
_version_ 1782480993574191104
author Reid, Sarah L.
Arestis, Nikolas J.
McIlhenny, Craig
Lamb, Gavin W. A.
author_facet Reid, Sarah L.
Arestis, Nikolas J.
McIlhenny, Craig
Lamb, Gavin W. A.
author_sort Reid, Sarah L.
collection PubMed
description Renal cell carcinoma (RCC) uncommonly metastasizes to the ureter and rarely to the contralateral ureter. We describe the presentation of 2 successive contralateral ureteric metastases from RCC in our institution. The first represents the only reported metachronous ureteric deposit on adjuvant sorafenib after laparoscopic radical nephrectomy for RCC. The other presented with a synchronous lesion after radiological work-up. Both lesions were treated with endoscopic excision and laser ablation with preservation of the renal unit and no local recurrence. We report these cases and discuss the literature.
format Online
Article
Text
id pubmed-4102019
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-41020192014-08-07 Contralateral Renal Cell Carcinoma Ureteric Metastases Can Arise on Tyrosine Kinase Adjuvant Therapy and Be Effectively Treated by Endoscopic Laser Excision and Ablation Reid, Sarah L. Arestis, Nikolas J. McIlhenny, Craig Lamb, Gavin W. A. Case Rep Urol Case Report Renal cell carcinoma (RCC) uncommonly metastasizes to the ureter and rarely to the contralateral ureter. We describe the presentation of 2 successive contralateral ureteric metastases from RCC in our institution. The first represents the only reported metachronous ureteric deposit on adjuvant sorafenib after laparoscopic radical nephrectomy for RCC. The other presented with a synchronous lesion after radiological work-up. Both lesions were treated with endoscopic excision and laser ablation with preservation of the renal unit and no local recurrence. We report these cases and discuss the literature. Hindawi Publishing Corporation 2014 2014-07-01 /pmc/articles/PMC4102019/ /pubmed/25105052 http://dx.doi.org/10.1155/2014/359352 Text en Copyright © 2014 Sarah L. Reid et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Reid, Sarah L.
Arestis, Nikolas J.
McIlhenny, Craig
Lamb, Gavin W. A.
Contralateral Renal Cell Carcinoma Ureteric Metastases Can Arise on Tyrosine Kinase Adjuvant Therapy and Be Effectively Treated by Endoscopic Laser Excision and Ablation
title Contralateral Renal Cell Carcinoma Ureteric Metastases Can Arise on Tyrosine Kinase Adjuvant Therapy and Be Effectively Treated by Endoscopic Laser Excision and Ablation
title_full Contralateral Renal Cell Carcinoma Ureteric Metastases Can Arise on Tyrosine Kinase Adjuvant Therapy and Be Effectively Treated by Endoscopic Laser Excision and Ablation
title_fullStr Contralateral Renal Cell Carcinoma Ureteric Metastases Can Arise on Tyrosine Kinase Adjuvant Therapy and Be Effectively Treated by Endoscopic Laser Excision and Ablation
title_full_unstemmed Contralateral Renal Cell Carcinoma Ureteric Metastases Can Arise on Tyrosine Kinase Adjuvant Therapy and Be Effectively Treated by Endoscopic Laser Excision and Ablation
title_short Contralateral Renal Cell Carcinoma Ureteric Metastases Can Arise on Tyrosine Kinase Adjuvant Therapy and Be Effectively Treated by Endoscopic Laser Excision and Ablation
title_sort contralateral renal cell carcinoma ureteric metastases can arise on tyrosine kinase adjuvant therapy and be effectively treated by endoscopic laser excision and ablation
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102019/
https://www.ncbi.nlm.nih.gov/pubmed/25105052
http://dx.doi.org/10.1155/2014/359352
work_keys_str_mv AT reidsarahl contralateralrenalcellcarcinomauretericmetastasescanariseontyrosinekinaseadjuvanttherapyandbeeffectivelytreatedbyendoscopiclaserexcisionandablation
AT arestisnikolasj contralateralrenalcellcarcinomauretericmetastasescanariseontyrosinekinaseadjuvanttherapyandbeeffectivelytreatedbyendoscopiclaserexcisionandablation
AT mcilhennycraig contralateralrenalcellcarcinomauretericmetastasescanariseontyrosinekinaseadjuvanttherapyandbeeffectivelytreatedbyendoscopiclaserexcisionandablation
AT lambgavinwa contralateralrenalcellcarcinomauretericmetastasescanariseontyrosinekinaseadjuvanttherapyandbeeffectivelytreatedbyendoscopiclaserexcisionandablation

Ejemplares similares